SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GSII - GENERAL SURGICAL INNOVATIONS, INC.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Elroy who wrote (82)10/16/1997 4:50:00 PM
From: Lighthouse   of 211
 
Yes $250K and above would be a Big Hairy Aggresive Goal for this indication. This $ figure would be for the procedure kit and not just the individual balloon sales. A higher ASP $200-$300 or more translates into under 1,000 procedures for the December quarter. Eight field reps of GSI and 5 distributors will be flogging this product, hope they hit some paydirt.

Generally sugeons are reluctant to change anything about procedures (thankfully); however, it appears that some of them are moving toward this indication quickly. Previously the incision to harvest the Saphenous Vein was one of the longest of any surgical procedure affecting the body. Infection and wound healing could be problematic and patients complained about the pain associated with the cut. Readmission into the hospital over the cut (when it does not heal properly) is a possibility.

Added cost is still an issue. Competition is still a very big issue. Learning curve is still an issue. Patient satisfaction appears NOT to be an issue. By all accounts patients are very happy with the procedure. GSI sued GDT over their Vasoview harvest product. JNJ is selling into this market and will butt heads with GSI (highly ironic that JNJ is GSI's big marketing partner). USS (GSI's old marketing partner) is selling in this field as well.

What got you interested in GSI?

Regards,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News